Related Experiment Video
Updated: Jul 10, 2026
03:37
Self-Administration of Drugs in Mouse Models of Feeding and Obesity
Published on: June 8, 2021
New for old? Risperidone long-acting injection in older patients
Pamela Hudson-Jessop1, Brendan Hughes, Neridah Brinkley
1Nambour Hospital, Nambour, Qld, Australia. pamela_hudson-jessop@health.qld.gov.au
Summary
Risperidone long-acting injection was trialled in six older patients with psychotic disorders. While two patients continued treatment, others discontinued due to side effects or lack of efficacy, suggesting a limited role requiring further research.
Area of Science:
- Psychogeriatrics
- Pharmacology
- Clinical Psychiatry
Background:
- Psychotic disorders in older adults present unique treatment challenges.
- Long-acting injectable antipsychotics offer potential benefits for medication adherence.
- Risperidone long-acting injection is a treatment option for psychosis.
Observation:
- A case series of six older patients receiving risperidone long-acting injection was evaluated.
- Patient outcomes were assessed based on treatment continuation, adverse effects, and response.
- The study focused on the utility of this injectable in a psychogeriatric care setting.
Findings:
- Two out of six patients successfully continued risperidone long-acting injection.
- Three patients discontinued due to a combination of adverse effects and insufficient response.
- One patient discontinued solely due to adverse effects.
Implications:
- Risperidone long-acting injection may be a viable option for select older patients with psychotic disorders.
- Adverse side effects and non-response are significant considerations for this population.
- Further research is necessary to define the precise role and optimize the use of risperidone long-acting injection in psychogeriatrics.
Related Concept Videos
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:21Drug Accumulation During Multiple Dosing: Repetitive IV Injections
Calculating drug dosage and accumulation in multiple-dose regimens is crucial for achieving therapeutic efficacy while avoiding toxicity. This involves determining the plasma drug concentrations over time to optimize dosing schedules. The principle of superposition is fundamental in this process, allowing for the prediction of drug concentration in plasma following multiple doses based on single-dose data.The principle of superposition asserts that the plasma concentration-time curves from...
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...